Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by WilmerHale ordered by Published Date Descending.
Links to Result pages
 
1 2 3  
>>Next
 
Title
Country
Organisation
Author
Date
1
The Guide To Monitorships: The Healthcare Industry
For nearly 15 years, the Department of Justice (DOJ) has used independent monitors to address compliance issues with companies accused of violations of healthcare fraud statutes and regulations.
United States
8 Jul 2019
2
7 Tips For Biotech Companies Seeking Capital In A Volatile Market
The article provides a recap of the 2018 market for early-stage public biotech companies...
United States
2 Jul 2019
3
The Potential Impacts Of The Nagoya Protocol On Global Public Health Research
This is typically accomplished through negotiation of an ABS agreement between the party seeking access and the provider country.
United States
28 Jun 2019
4
Developments In The Marijuana Industry And The Implications For Financial Institutions
The myriad—and conflicting—state, federal and international laws governing the burgeoning marijuana industry have created a complicated legal landscape for financial institutions.
United States
11 Feb 2019
5
False Claims Act: 2018 Year-In-Review
Federal False Claims Act recoveries in fiscal year 2018 amounted to $2.88 billion, down by roughly $600 million from the prior year and dropping below $3 billion for the first time in eight years.
United States
9 Jan 2019
6
What High Court Will Consider In Helsinn On-Sale Bar Case
The US Supreme Court may soon resolve an issue that has sparked much debate since the enactment of the Leahy-Smith America Invents Act—namely, whether under the AIA, an inventor's sale of an invention to a third party ...
United States
5 Dec 2018
7
Blurred Vision – Cannabis And Reporting
On 17 October, Canada legalised the recreational use of marijuana, following the passing of The Cannabis Act 2018 this summer.
UK
21 Nov 2018
8
Judgment Of The Court Of Justice Of The European Union Of July 25, 2018, In Case C-528/16 Confédération Paysanne And Others
On July 25, 2018, the Court of Justice (Court), sitting in a Grand Chamber, issued its judgment in Confédération paysanne and Others, by which it found that ...
European Union
7 Aug 2018
9
United States
18 May 2018
10
Brexit At Halfway: Pharma And Medical Devices
The object of this Alert is to highlight some practical implications of Brexit for the supply of pharmaceutical products and medical devices in the European Union (EU) and related action items...
United States
6 Apr 2018
11
False Claims Act: 2017 Year-In-Review
False Claims Act (FCA) recoveries topped $3.7 billion in fiscal year 2017, marking the eighth straight year of annual recoveries in excess of $3 billion.
United States
10 Jan 2018
12
Nations Press for International Restrictions to Govern Genetic Sequence Data
clash over access to and use of genetic sequence data (GSD) is currently brewing on several international fronts. To date, GSD has been routinely deposited in open-source databases such as GenBank of the National Center for Biotechnology Information ..
United States
19 May 2017
13
Finding A Way Through A Tight Deal Space
Last year's contentious U.S. presidential election is often blamed for the slowdown in dealmaking activity in the life sciences space.
United States
17 May 2017
14
Health Care Industry Cybersecurity Task Force Report Identifies Imperatives for Reform
Several media organizations this week published a pre-release copy of the report of the Health Care Industry Cybersecurity Task Force established pursuant to the Cybersecurity Act of 2015.
United States
8 May 2017
15
Practice Tips for Patentees Asserting Method-of-Treatment Claims Involving Divided
Do physicians ‘‘condition participation'' of drug therapy based on patients' compliance with drug manufacturer instructions regarding how to take drugs? Do physicians withhold medically necessary drug therapy from patients when patients fail or refuse to take a drug in accordance with the instructions in the label?
United States
4 Apr 2017
16
United States
29 Mar 2017
17
Allergan And Editas Medicine Enter Into Strategic R&D Alliance
Editas Medicine, Inc., a leading genome editing company, and Allergan plc, a leading global pharmaceutical company, announced that Allergan's wholly-owned subsidiary—Allergan Pharmaceuticals International Limited—and Editas Medicine . . .
United States
20 Mar 2017
18
Park Square And Wilmerhale Release 17th Annual Technology And Life Sciences Compensation And Entrepreneurship Study
Growth rate in salaries for private company technology executives track higher than comparable life science leaders for the second year in a row.
United States
15 Feb 2017
19
ConforMIS Inc. Secures $50M In Debt Financing From Oxford Finance
ConforMIS Inc. (CFMS)—a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants that are...
United States
17 Jan 2017
20
Wilmerhale Reps Nantero In $21M Financing For Carbon Nanotube Computer Memory
Nantero Inc., the nanotechnology company developing next-generation memory using carbon nanotubes, announced the closing of more than $21 million financing round.
United States
21 Dec 2016
Links to Result pages
 
1 2 3  
>>Next